Espondiloartritis anquilosante

A Phase 3 Randomized, Placebo-Controlled, Double-Blind Program to Evaluate the Efficacy and Safety of Upadacitinib in Adult Subjects with Ankylosing Spondylitis

Study Information

Conquest Research needs volunteers for an ankylosing spondylitis trial evaluating a medication designed for the treatment of ankylosing spondylitis. You may qualify if you:

Eligible participants will receive study-related care at no cost. Compensation for time and travel may be available. No medical insurance is required for participation.